← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2015Last known activity
Dec 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT07271030Lead sponsorN/ADec 31, 2025
- NCT07271030OfficialN/ADec 31, 2025
- NCT06435650Sponsor investigatorN/AJul 1, 2023
- NCT06435650OfficialN/AJul 1, 2023
- NCT06435650Lead sponsorN/AJul 1, 2023
- NCT02525107CollaboratorPhase 3Sep 1, 2015
Details
- Last known activity
- Dec 31, 2025